Use of chitin-based medicament for the treatment in milk teeth.

Phase 3

Completed

Brief Summary: The literature cites Chitosan’s hemostaticcapability by functioning as a scaffold for clot formation and providing astrong primary closure at the wound site. Chitosan is said to haveanti-inflammatory properties help in tissue regeneration and the hemostaticactivity is attributed to its positively charged amino functional group causingan electrostatic interaction with the negatively charged blood cell leading toclot formation which in turn offers an antibacterial barrier.

Therefore, the goal of this study is toassess the effectiveness of Chitosan as a pulpotomy medicament both clinicallyand radiographically and if successful recommend its use for pulpotomyprocedures in the future.

Recruitment & Eligibility

Inclusion Criteria

1.Large carious lesion in an otherwise restorable primary tooth 2.No spontaneous pain.
3.More than two-thirds of the root length is still present 4.No sign of internal or external root resorption 5.Hemorrhage from the amputated pulp site is controlled within 5 minutes.

Exclusion Criteria

1.Not fulfilling the above-mentioned clinical or radiographic criteria.
2.Inability to achieve hemostasis within 5 minutes of pressure application with a moist cotton pellet.
3.Bright red bleeding at the amputated pulp site.

Primary Outcome Measures

Name	Time	Method
This study aims to clinically and radiographically evaluate the success of Chitosan as a medicament for pulpotomy.	6 months

Secondary Outcome Measures

Name	Time	Method
Chitosan can be used as an alternative to formocresol for pulpotomy procedure.	6 months

Locations (1): A B Shetty Memorial Institute of Dental Sciences
🇮🇳
Kannada, KARNATAKA, India
A B Shetty Memorial Institute of Dental Sciences
🇮🇳Kannada, KARNATAKA, India
Nidhish Krishna R
Principal investigator
9566219482
nkris2007@gmail.com